Search
                    Renal Insufficiency Clinical Trials
A listing of 4  Renal Insufficiency  clinical trials  actively recruiting volunteers for paid trials and research studies in various therapeutic areas.
            1 - 4 of 4
        
        
    
                There are currently 4 active clinical trials seeking participants for Renal Insufficiency research studies. The states with the highest number of trials for Renal Insufficiency participants are Florida, California, Texas and New York.
            
                Featured Trial
                
                Healthy Participants Needed (Colonoscopy + Cancer Screening)
            
        Recruiting
            
        Earn $325 - $475 in electronic payment card compensation for your time and effort by participating in a clinical study to develop a blood test that may one day help screen for colon cancer. Take a quick quiz to see if you qualify.
    
    
                            Conditions: 
                                    
        
            
                        Healthy
                    
                                    
                        Healthy Volunteers
                    
                                    
                        Healthy Subjects
                    
                                    
                        Healthy Volunteer
                    
                                    
                        Healthy Participants
                    
                                    Featured Offer
                
                Lose Weight with GLP-1 Medications
            
        Recruiting
            
        Policy Lab has partnered with OnlineSemaglutide.org to offer trusted access to semaglutide and other GLP-1 medications, including generic alternatives to Ozempic® and Wegovy®. 
GLP-1 medications are scientifically backed to help individuals achieve significant weight loss—on average, 15-20% of body weight within a year.
As a valued user, you’re eligible for $50 off your first program with code policy-lab-50.
    GLP-1 medications are scientifically backed to help individuals achieve significant weight loss—on average, 15-20% of body weight within a year.
As a valued user, you’re eligible for $50 off your first program with code policy-lab-50.
                            Conditions: 
                                    
        
            
                        Overweight
                    
                                    
                        Overweight and Obesity
                    
                                    
                        Obesity
                    
                                    
                        Weight Loss
                    
                                    
                        Morbid Obesity
                    
                                    Featured Trial
                
                Stroke Clinical Study
            
        Recruiting
            
        A clinical study for people that suffer with Stroke
    
    
                            Conditions: 
                                    
        
            
                        Stroke
                    
                                    Featured Trial
                
                Chronic Kidney Disease (CKD) Clinical Study
            
        Recruiting
            
        A clinical study for people that suffer with Chronic Kidney Disease (CKD)
    
    
                            Conditions: 
                                    
        
            
                        Chronic Kidney Disease (CKD)
                    
                                    
                
                                    Product Surveillance Registry
                                
            
            
        Recruiting
                            
            
                The purpose of the Registry is to provide continuing evaluation and periodic reporting of safety and effectiveness of Medtronic market-released products. The Registry data is intended to benefit and support interests of patients, hospitals, clinicians, regulatory bodies, payers, and industry by streamlining the clinical surveillance process and facilitating leading edge performance assessment via the least burdensome approach.             
        
        
    Gender:
                ALL
            Ages:
                All
            Trial Updated:
                07/24/2025
            
            Locations: Not set, Birmingham, Alabama  +381 locations         
        
        
            Conditions: Cardiac Rhythm Disorders, Urological Disorders, Neurological Disorders, Cardiovascular Disorders, Digestive Disorders, Intracranial Aneurysm, Mechanical Circulatory Support, Respiratory Therapy, Aortic, Peripheral Vascular and Venous Disorders, Minimally Invasive Surgical Procedures, Diagnostic Techniques and Procedures, Surgical Procedures, Operative, Renal Insufficiency, Neurovascular, Coronary Artery Disease, Ear, Nose and Throat Disorder
        
            
        
    
                
                                    SAVE-FistulaS: the SelfWrap-Assisted ArterioVEnous Fistulas Study
                                
            
            
        Recruiting
                            
            
                This is a prospective, randomized, multi-center clinical trial for chronic kidney disease (CKD) patients referred for creation of a new arteriovenous fistula (AVF) in order to assess the safety and effectiveness of SelfWrap, a bioabsorbable perivascular wrap.             
        
        
    Gender:
                ALL
            Ages:
                18 years and above
            Trial Updated:
                03/26/2025
            
            Locations: AKDHC Bullhead City, Bullhead City, Arizona  +21 locations         
        
        
            Conditions: Chronic Kidney Diseases, End Stage Renal Disease, Arteriovenous Fistula, Hemodialysis Access Failure, ESRD, Vascular Access Complication, Renal Failure, Catheter Complications, Catheter Dysfunction, Renal Insufficiency
        
            
        
    
                
                                    Spironolactone in CKD Enabled by Chlorthalidone: PILOT
                                
            
            
        Recruiting
                            
            
                Highly prevalent among patients with chronic kidney disease (CKD) and poorly controlled blood pressure (BP), is a modifiable risk factor to abrogate both kidney failure progression and cardiovascular (CV) disease. Spironolactone (SPL), a mineralocorticoid receptor antagonist, is widely used to treat resistant hypertension, however one of the most common side effects is an increase of serum potassium (K). This side effect occurs frequently in those who suffer from CKD. Alternatively, chlorthalido...  Read More             
        
        
    Gender:
                ALL
            Ages:
                Between 19 years and 110 years
            Trial Updated:
                08/11/2023
            
            Locations: Richard L Roudebush VA Medical Center, Indianapolis, Indiana         
        
        
            Conditions: Renal Insufficiency, Chronic Hypertension
        
            
        
    
                
                                    Study to Evaluate the Pharmacokinetics, Safety, and Pharmacodynamics of INCB054707 in Participants With Normal and Impaired Renal Function and Participants on Hemodialysis
                                
            
            
        Recruiting
                            
            
                This is a multi-center, open-label, parallel-group study to evaluate oral doses of INCB054707 in participants with varying levels of renal function or impairment.             
        
        
    Gender:
                All
            Ages:
                Between 18 years and 82 years
            Trial Updated:
                02/17/2023
            
            Locations: Orlando Clinical Research Center, Orlando, Florida  +1 locations         
        
        
            Conditions: Renal Insufficiency, Kidney Diseases
        
            
        
    1 - 4 of 4
            
            
        